A股異動 | 樂鑫科技跌逾7% 擬定增募資不超17.78億元
樂鑫科技(688018.SH)今日盤中一度跌7.5%至210.21元。樂鑫科技上週五(14日)晚間公佈2025年度向特定對象發行A股股票預案,本次向特定對象發行股票募集資金總額不超過人民幣17.78億元(含本數),扣除發行費用後的淨額擬投資於以下項目:Wi-Fi7路由器芯片研發及產業化項目、Wi-Fi7智能終端芯片研發及產業化項目、基於RISC-V自研IP的AI端側芯片研發及產業化項目、上海研發中心建設項目及補充流動資金。(格隆匯)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.